Immunohistochemistry Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global immunohistochemistry market looks promising with opportunities in diagnostics, research, and forensic applications. The global immunohistochemistry market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing demand for better health related solutions and diagnostic services, rising awareness of histopathology, and increasing prevalence of chronic and infectious diseases.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global immunohistochemistry market report, please download the report brochure.
The study includes trends and forecast for the global immunohistochemistry market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that antibodies will remain the largest product segment over the forecast period due to increasing demand for personalized medicines and rising use of research antibodies for drug development.
Within this market, diagnostics will remain the largest segment by application over the forecast period due to increasing prevalance of chronic and infectious diseases and growing geriatric population.
North America will remain the largest region over the forecast period due to rising demand for companion diagnostic assay kits, favorable government initiatives for empowering continuous research on Immunohistochemistry (IHC) by financing them, and increasing geriatric population in the region.
Features of the Global Immunohistochemistry Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global immunohistochemistry market by product (antibodies, reagents, equipment, and kits), application (diagnostics (cancer, infectious, nephrological diseases, autoimmune diseases, neurological diseases, and other diseases), research, and forensic), end user (hospitals, diagnostic laboratories, academic institutes, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global immunohistochemistry market?
Q.5 What are the business risks and threats to the global immunohistochemistry market?
Q.6 What are the emerging trends in the immunohistochemistry market and the reasons behind them?
Q.7 What are some changing demands of customers in the immunohistochemistry market?
Q.8 What are the new developments in the immunohistochemistry market? Which companies are leading these developments?
Q.9 Who are the major players in the immunohistochemistry market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the immunohistochemistry market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global immunohistochemistry market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Antibodies, Reagents, Equipment, and Kits), Application (Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic), and End User (Hospitals, Diagnostic Laboratories, Academic Institutes, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Italy, Germany, and France), Asia Pacific (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global immunohistochemistry market looks promising with opportunities in diagnostics, research, and forensic applications. The global immunohistochemistry market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing demand for better health related solutions and diagnostic services, rising awareness of histopathology, and increasing prevalence of chronic and infectious diseases.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global immunohistochemistry market report, please download the report brochure.
The study includes trends and forecast for the global immunohistochemistry market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Antibodies
- Reagents
- Equipment
- Kits
- Diagnostics
- Cancer
- Infectious
- Nephrological Diseases
- Autoimmune Diseases
- Neurological Diseases
- Other Diseases
- Research
- Forensic
- Hospitals
- Diagnostic Laboratories
- Academic Institutes
- Others
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Italy
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that antibodies will remain the largest product segment over the forecast period due to increasing demand for personalized medicines and rising use of research antibodies for drug development.
Within this market, diagnostics will remain the largest segment by application over the forecast period due to increasing prevalance of chronic and infectious diseases and growing geriatric population.
North America will remain the largest region over the forecast period due to rising demand for companion diagnostic assay kits, favorable government initiatives for empowering continuous research on Immunohistochemistry (IHC) by financing them, and increasing geriatric population in the region.
Features of the Global Immunohistochemistry Market
- Market Size Estimates: Global immunohistochemistry market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global immunohistochemistry market size by various segments, such as product, application, and end user, in terms of value.
- Regional Analysis: Global immunohistochemistry market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different products, applications, end users, and regions for the global immunohistochemistry market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global immunohistochemistry market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global immunohistochemistry market by product (antibodies, reagents, equipment, and kits), application (diagnostics (cancer, infectious, nephrological diseases, autoimmune diseases, neurological diseases, and other diseases), research, and forensic), end user (hospitals, diagnostic laboratories, academic institutes, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global immunohistochemistry market?
Q.5 What are the business risks and threats to the global immunohistochemistry market?
Q.6 What are the emerging trends in the immunohistochemistry market and the reasons behind them?
Q.7 What are some changing demands of customers in the immunohistochemistry market?
Q.8 What are the new developments in the immunohistochemistry market? Which companies are leading these developments?
Q.9 Who are the major players in the immunohistochemistry market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the immunohistochemistry market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global immunohistochemistry market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Antibodies, Reagents, Equipment, and Kits), Application (Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic), and End User (Hospitals, Diagnostic Laboratories, Academic Institutes, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Italy, Germany, and France), Asia Pacific (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Immunohistochemistry Market Trends and Forecast
3.3: Global Immunohistochemistry Market by Product
3.3.1: Antibodies
3.3.2: Reagents
3.3.3: Equipment
3.3.4: Kits
3.4: Global Immunohistochemistry Market by Application
3.4.1: Diagnostics
3.4.1.1: Cancer
3.4.1.2: Infectious
3.4.1.3: Nephrological Diseases
3.4.1.4: Autoimmune Diseases
3.4.1.5: Neurological Diseases
3.4.1.6: Other Diseases
3.4.2: Research
3.4.3: Forensic
3.5: Global Immunohistochemistry Market by End User
3.5.1: Hospitals
3.5.2: Diagnostic Laboratories
3.5.3: Academic Institutes
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Immunohistochemistry Market by Region
4.2: North American Immunohistochemistry Market
4.2.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.2.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.2.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.2.4: The United States Immunohistochemistry Market
4.2.5: The Canadian Immunohistochemistry Market
4.2.6: The Mexican Immunohistochemistry Market
4.3: European Immunohistochemistry Market
4.3.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.3.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.3.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.3.4: The Immunohistochemistry Market of the United Kingdom
4.3.5: The Italian Immunohistochemistry Market
4.3.6: The German Immunohistochemistry Market
4.3.7: The French Immunohistochemistry Market
4.4: APAC Immunohistochemistry Market
4.4.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.4.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.4.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.4.4: The Chinese Immunohistochemistry Market
4.4.5: The Indian Immunohistochemistry Market
4.4.6: The Japanese Immunohistochemistry Market
4.5: ROW Immunohistochemistry Market
4.5.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.5.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.5.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.5.4: Brazilian Immunohistochemistry Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Immunohistochemistry Market by Product
7.1.2: Growth Opportunities for the Global Immunohistochemistry Market by Application
7.1.3: Growth Opportunities for the Global Immunohistochemistry Market by End User
7.1.4: Growth Opportunities for the Global Immunohistochemistry Market by Region
7.2: Emerging Trends in the Global Immunohistochemistry Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Immunohistochemistry Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunohistochemistry Market
7.3.4:Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: F. Hoffmann-La Roche Ltd.
8.2: Agilent Technologies, Inc.
8.3: Danaher Corporation
8.4: PHC Holding Corporation
8.5: Biocare Medical, LLC.
8.6: Merck KGaA
8.7: Bio-Rad Laboratories, Inc.
8.8: Bio-Techne Corporation
8.9: Abcam Plc
8.10: Becton, Dickinson And Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Immunohistochemistry Market Trends and Forecast
3.3: Global Immunohistochemistry Market by Product
3.3.1: Antibodies
3.3.2: Reagents
3.3.3: Equipment
3.3.4: Kits
3.4: Global Immunohistochemistry Market by Application
3.4.1: Diagnostics
3.4.1.1: Cancer
3.4.1.2: Infectious
3.4.1.3: Nephrological Diseases
3.4.1.4: Autoimmune Diseases
3.4.1.5: Neurological Diseases
3.4.1.6: Other Diseases
3.4.2: Research
3.4.3: Forensic
3.5: Global Immunohistochemistry Market by End User
3.5.1: Hospitals
3.5.2: Diagnostic Laboratories
3.5.3: Academic Institutes
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Immunohistochemistry Market by Region
4.2: North American Immunohistochemistry Market
4.2.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.2.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.2.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.2.4: The United States Immunohistochemistry Market
4.2.5: The Canadian Immunohistochemistry Market
4.2.6: The Mexican Immunohistochemistry Market
4.3: European Immunohistochemistry Market
4.3.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.3.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.3.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.3.4: The Immunohistochemistry Market of the United Kingdom
4.3.5: The Italian Immunohistochemistry Market
4.3.6: The German Immunohistochemistry Market
4.3.7: The French Immunohistochemistry Market
4.4: APAC Immunohistochemistry Market
4.4.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.4.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.4.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.4.4: The Chinese Immunohistochemistry Market
4.4.5: The Indian Immunohistochemistry Market
4.4.6: The Japanese Immunohistochemistry Market
4.5: ROW Immunohistochemistry Market
4.5.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.5.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.5.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.5.4: Brazilian Immunohistochemistry Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Immunohistochemistry Market by Product
7.1.2: Growth Opportunities for the Global Immunohistochemistry Market by Application
7.1.3: Growth Opportunities for the Global Immunohistochemistry Market by End User
7.1.4: Growth Opportunities for the Global Immunohistochemistry Market by Region
7.2: Emerging Trends in the Global Immunohistochemistry Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Immunohistochemistry Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunohistochemistry Market
7.3.4:Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: F. Hoffmann-La Roche Ltd.
8.2: Agilent Technologies, Inc.
8.3: Danaher Corporation
8.4: PHC Holding Corporation
8.5: Biocare Medical, LLC.
8.6: Merck KGaA
8.7: Bio-Rad Laboratories, Inc.
8.8: Bio-Techne Corporation
8.9: Abcam Plc
8.10: Becton, Dickinson And Company
